Danaher Corp. has completed its $9.9 billion acquisition of Irvine-based Masimo Corp.
Masimo, which specializes in non-invasive patient monitoring devices, is now a wholly-owned subsidiary of Danaher within its diagnostics segment but will continue to operate under the Masimo brand.
With the closing of the deal, Masimo’s common stock ceased trading on the Nasdaq.
Related links:
